HC Wainwright & Co. Maintains Buy on Evofem Biosciences, Lowers Price Target to $2.5
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Evofem Biosciences (NASDAQ:EVFM) with a Buy and lowers the price target from $4 to $2.5.
12 Health Care Stocks Moving In Tuesday’s Pre-Market Session
Gainers
Viridian Therapeutics (NASDAQ:VRDN) stock rose 22.49% to $19.17 during Tuesday's pre-market session. The company's market cap stands at $331.8 million.
Evofem Biosciences Highlights Publication On ‘the variability of contraceptive clinical trial design and its impact on efficacy outcomes’ In Peer-Reviewed Journal Advances In Therapy
Evofem Biosciences, Inc., (NASDAQ: EVFM) today announced that a manuscript on the variability of contraceptive clinical trial design and its impact on efficacy outcomes has been published in the peer-reviewed
Evofem Biosciences’s Return On Capital Employed Insights
According to data from Benzinga Pro, during Q2, Evofem Biosciences's (NASDAQ:EVFM) reported sales totaled $1.86 million. Despite a 8.31% increase in earnings, the company posted a loss of $41.14 million.
‘Schitt’s Creek’ Star Annie Murphy Headlines New Campaign For Phexxi Contraceptive
Evofem Biosciences, Inc. (NASDAQ: EVFM) has recruited Emmy Award-winning “Schitt’s Creek” actress Annie Murphy to star in a new marketing campaign for its Phexxi hormone-free contraceptive.
Evofem, Immutep Shares Spike To Session High Following TipRanks Article ‘2 “Strong Buy” Penny Stocks That Offer Massive Potential Gains’
https://www.tipranks.com/news/article/2-strong-buy-penny-stocks-that-offer-massive-potential-gains/
The Daily Biotech Pulse: AzurRx Jumps On Data, Agios’ Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 17)
The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 16)